Augmented rescue of macroglobulins by supplementation of anti-snake venom with methanolic extract of Andrographis paniculata in Naja naja envenomation

• Published in: 3 Biotech 2022-11, Vol.12 (11), p.310-310, Article 310
• Main Authors: Nayak, Akshatha G., Aithal, P. Ashwini, Kumar, Nitesh, Shenoy, Smita, Roche, Maya
• Format: Article
• Language: English
• Subjects: Agriculture; Andrographis paniculata; Bioinformatics; Biomaterials; Biotechnology; Blood plasma; Cancer Research; Chemistry; Chemistry and Materials Science; Chymotrypsin; Enzymes; Experiments; Homology; In vitro methods and tests; Macroglobulins; Naja naja; Original Article; Proteins; Snakes; Stem Cells; Supplements; Survival; Venom; Venomous snakes
• ISSN: 2190-572X; 2190-5738
• DOI: 10.1007/s13205-022-03379-w

Proteins of the macroglobulin family are prime targets of venom enzymes in snake bite. A massive reduction in the active concentration of these multifunctional proteins in snake bite, makes the living system vulnerable to dysregulation. This study investigates the ability of Indian polyvalent anti-snake venom (ASV), methanolic extract of Andrographis paniculata (MAP) and their combination in rescuing human alpha 2-macroglobulin (A2MG) and its homologues in rat plasma, from inactivation by Naja naja (N.N) venom enzymes. In-vitro experiments were conducted with heparinized human plasma and in-vivo experiments with female Wistar rats. Along with appropriate controls, there were 3 test groups in in-vitro and 8 test groups in in-vivo experiments. The in-vitro test groups were exposed to N.N venom for zero, 30 or 90 min prior to incubation with ASV or MAP or reduced ASV supplemented with MAP and incubated for 16 h at 37 °C. Chymotrypsin-bound esterase (CTBE) activity of A2MG was estimated. Rats were administered the venom intramuscularly and treated with ASV/MAP/ASV + MAP. CTBE activity of macroglobulin homologues was measured on day 1, 7 and 14. Survival of animals was noted. In human plasma, addition of ASV or MAP or ASV + MAP prevented loss of A2MG activity maximally to the extent of 88–100% ( p  = 0.001). In rats, reduced concentration of ASV supplemented with MAP showed complete rescue of macroglobulin homologues and 90% survival. The compulsive evidence from this study, underscores the merits of using this multipronged strategy in rescuing the macroglobulins and improving survival in envenomation due to N.N.